Portfolio (Quarterly)
Guide ↗
Blue Owl Capital Holdings LP
· CIK 0001858703| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AKTS | AKTIS ONCOLOGY INC | Healthcare | 3,161,348.0 | $56.6M | 15.20% | NEW | — | $17.89 | +9.3% |
| 2 | LRMR | LARIMAR THERAPEUTICS INC | Healthcare | 7,120,007.0 | $32.0M | 8.61% | +296K | +4.3% | $4.50 | -13.6% |
| 3 | — | ENGENE HOLDINGS INC | — | 4,416,353.0 | $30.1M | 8.08% | +1.1M | +31.4% | $6.81 | — |
| 4 | NCDL | NUVEEN CHURCHILL DIRECT LEND | Financial Services | 2,143,626.0 | $27.3M | 7.33% | — | — | $12.72 | +3.5% |
| 5 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 1,909,764.0 | $27.1M | 7.29% | -441K | -18.8% | $14.21 | +10.7% |
| 6 | — | BLUE OWL CAPITAL CORPORATION | — | 2,045,070.0 | $22.6M | 6.08% | — | — | $11.06 | — |
| 7 | MPLT | MAPLIGHT THERAPEUTICS INC | Healthcare | 1,005,929.0 | $20.5M | 5.50% | +679K | +207.6% | $20.33 | +41.3% |
| 8 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 2,941,525.0 | $15.6M | 4.18% | -525K | -15.1% | $5.29 | -64.8% |
| 9 | CNTX | CONTEXT THERAPEUTICS INC | Healthcare | 5,089,015.0 | $13.3M | 3.58% | -2.3M | -31.5% | $2.62 | -17.6% |
| 10 | HLLY | HOLLEY INC | Consumer Cyclical | 4,236,888.0 | $13.0M | 3.50% | +90K | +2.2% | $3.07 | -11.4% |
| 11 | EYPT | EYEPOINT INC | Healthcare | 912,594.0 | $11.8M | 3.16% | +520K | +132.4% | $12.89 | +2.7% |
| 12 | CRVS | CORVUS PHARMACEUTICALS INC | Healthcare | 545,000.0 | $8.0M | 2.14% | NEW | — | $14.63 | -6.6% |
| 13 | CNDT | CONDUENT INC | Technology | 5,036,595.0 | $6.4M | 1.73% | +214K | +4.4% | $1.28 | +8.6% |
| 14 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 302,638.0 | $6.3M | 1.70% | +90K | +42.3% | $20.95 | +23.2% |
| 15 | AQST | AQUESTIVE THERAPEUTICS INC | Healthcare | 1,347,932.0 | $5.6M | 1.50% | +823K | +156.8% | $4.15 | +0.5% |
| 16 | RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | 61,455.0 | $5.3M | 1.44% | NEW | — | $86.97 | +7.7% |
| 17 | — | COMPASS PATHWAYS PLC | — | 1,804,504.0 | $5.1M | 1.38% | NEW | — | $2.85 | — |
| 18 | IMMX | IMMIX BIOPHARMA INC | Healthcare | 547,552.0 | $5.0M | 1.34% | -439K | -44.5% | $9.11 | +10.9% |
| 19 | IMA | IMAGENEBIO INC | Healthcare | 959,337.0 | $4.8M | 1.29% | +136K | +16.4% | $5.00 | +13.6% |
| 20 | — | CIVEO CORP CDA | — | 180,475.0 | $4.8M | 1.28% | -190K | -51.3% | $26.46 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
82.2%
Financial Services
9.2%
Consumer Cyclical
4.3%
Technology
2.9%
Real Estate
0.9%
Energy
0.4%